(Adnkronos)
The covid AstraZeneca vaccine “is safe and effective”. Today Italy, after the news relating to the green light of the EMA, begins to administer the doses of the drug produced by the Anglo-Swedish multinational. The ok came yesterday afternoon, with the conference of experts from the European drug agency. After the stop, linked to the signaling of thrombotic events, we start again. The AstraZeneca vaccine, says the EMA, “is not associated with an increased overall risk of thromboembolic events and blood clots.”
EMA
“Some countries have suspended vaccinations. The scientific conclusion we have reached gives countries the information to make an informed decision regarding the use of the AstraZeneca vaccine in their vaccination campaign,” said Emer Cooke, executive director of EMA, reiterating. that “its benefits and the protection of people from Covid-19 outweigh the possible risks“Cooke then said that” we will initiate further investigations to understand more “about the” rare “adverse events reported after vaccination with AstraZeneca.” During the investigation and review activities “initiated on some reports,” we began to see a small number of cases of a rare and unusual but very serious bleeding disorder and this observation triggered a further focused review, “Cooke noted. The agency has made available to the various states” the information to make an informed decision. And Italy, today at 3 pm, will resume administering the vaccine.
DRAGHI
“The Italian government welcomes the EMA’s pronouncement on the AstraZeneca vaccine. The administration of the Astrazeneca vaccine will resume as early as Friday. “The government’s priority remains that of achieving the greatest number of vaccinations in the shortest possible time,” said Prime Minister Mario Draghi.
AIFA
Green light from the AIFA: “The reasons behind the precautionary ban on the use of vaccine batches, issued on March 15, 2021, have disappeared. Therefore” today “as soon as the Committee for Drugs for Human Use (CHMP) will issue its opinion, Aifa will revoke the ban on the use of the AstraZeneca vaccine, thus allowing a complete resumption of the vaccination campaign starting at 15.00 “, announced the Italian Medicines Agency, after consulting the Minister of Health, the management General of Prevention and the Higher Health Council. “In turn, the communications of the individual regions have arrived announcing the imminent resumption of vaccinations with the drug.
ASTRAZENECA
At the end of the day, the company note: “There is no increased overall risk of thrombosis with Astrazeneca’s Covid-19 vaccine,” said AstraZeneca, highlighting that “it will continue to work closely with the authorities. to ensure appropriate use of the Covid-19 vaccine “. The multinational “recognizes and will implement the recommendations of the Prac (the Pharmacovigilance Risk Assessment Committee of the Ema, ed), including the updating of information on the product, continuing to understand the nature and relevance of these events to ensure that the safe administration of the vaccine to continue during this public health crisis. “
–
